Asundexian inferior to apixaban for stroke prevention in atrial fibrillation: Study
Asundexian 50 mg daily was inferior to apixaban for stroke and systemic embolism prevention in high-risk patients with atrial fibrillation (AF), according to late-breaking research presented in a Hot Line session Sept. 1 ...
Sep 2, 2024
0
0